FENOFIBRIC ACID DR 135 MG CAP
For 30 capsules
Pharmacies pay
$8.59 filed
30 × $0.2863 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$14.88 estimated
$8.59 + $1.29 (15%) + $5.00 fee per fill = $14.88
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
FENOFIBRIC ACID DR 135 MG CAP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as fenofibric acid.
FDA gives its dosage form as capsule, delayed release and its route as oral.
FDA lists 4 labelers (the companies named on the label) for its NDCs, among them Amneal Pharmaceuticals of New York LLC, Aurobindo Pharma Limited and Alembic Pharmaceuticals Inc.
FDA’s Established Pharmacologic Class for it is Peroxisome Proliferator Receptor alpha Agonist.
The NADAC file of 2026-10-14 prices it under 7 NDCs (National Drug Codes); the FDA directory lists 4 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $8.59 for 30 capsules (30 × $0.2863 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.
What NADAC measures · Why 30 capsules · NADAC explanation codes
The 4 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Alembic Pharmaceuticals Inc. | 1 | $0.2863 per EA filed |
| Amneal Pharmaceuticals of New York LLC | 1 | $0.2863 per EA filed |
| Aurobindo Pharma Limited | 1 | $0.2863 per EA filed |
| Leading Pharma, LLC | 1 | $0.2863 per EA filed |
| Not listed as a package in the FDA directory | 3 | $0.2863 per EA filed |
All 7 NDCs, with labeler and price
- 00115-1325-10 · Amneal Pharmaceuticals of New York LLC · $0.2863 per EA · eff. 2026-09-23 filed
- 00115-1555-10 · not listed as a package in the FDA directory · $0.2863 per EA · eff. 2026-09-23 filed
- 42385-0945-90 · not listed as a package in the FDA directory · $0.2863 per EA · eff. 2026-09-23 filed
- 42571-0348-90 · not listed as a package in the FDA directory · $0.2863 per EA · eff. 2026-09-23 filed
- 59651-0217-90 · Aurobindo Pharma Limited · $0.2863 per EA · eff. 2026-09-23 filed
- 62332-0245-90 · Alembic Pharmaceuticals Inc. · $0.2863 per EA · eff. 2026-09-23 filed
- 69315-0282-09 · Leading Pharma, LLC · $0.2863 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
1 other product in the NADAC file shares the FDA nonproprietary name fenofibric acid with FENOFIBRIC ACID DR 135 MG CAP.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| FENOFIBRIC ACID DR 45 MG CAP | $0.16106 per EA filed | We don’t know yet |
| FENOFIBRIC ACID DR 135 MG CAP this page | $0.2863 per EA filed | We don’t know yet |
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Compared with its class
The middle of its 7 NDCs’ NADAC prices is $0.2863 per EA filed.
Of the 23 other products in FDA’s Peroxisome Proliferator Receptor alpha Agonist class priced per EA, 9 have a higher middle NADAC price and 14 a lower one. The one in the middle is FENOFIBRATE 200 MG CAPSULE, at $0.16437 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 capsules? Is it lower than what I would pay through my insurance?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Related pages
Its pharmacologic class
Related in the same class
- PIOGLITAZONE HCL 15 MG TABLET
- GEMFIBROZIL 600 MG TABLET
- PIOGLITAZONE-METFORMIN 15-500
- PIOGLITAZONE-GLIMEPIRIDE 30-2
- ALOGLIPTIN-PIOGLIT 25-15 MG TB